Literature DB >> 21567934

Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans.

Ranad Shaheen1, Mohammed Al-Owain, Eissa Faqeih, Nadia Al-Hashmi, Ali Awaji, Zayed Al-Zayed, Fowzan S Alkuraya.   

Abstract

Bruck syndrome (BS) is an autosomal recessive syndromic form of osteogenesis imperfecta (OI) that is characterized by the additional presence of pterygium formation. We have recently shown that FKBP10 previously reported as a novel autosomal recessive OI gene also defines a novel Bruck syndrome locus (BKS3). In this manuscript, we extend our analysis to describe a mutation previously described in isolated OI patients and show that it results in BS phenotype in a Saudi family. More interestingly, we describe a novel FKBP10 mutation that results in isolated OI as well as BS phenotype in the same family. These results, combined with recently published work, confirm that FKBP10 is a bonafide BS locus and lay the foundation for future research into modifiers that underlie the phenotypic heterogeneity of FKBP10 mutations.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567934     DOI: 10.1002/ajmg.a.34025

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  26 in total

Review 1.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Authors:  Gretl Hendrickx; Eveline Boudin; Wim Van Hul
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

2.  FKBP10 depletion enhances glucocerebrosidase proteostasis in Gaucher disease fibroblasts.

Authors:  Derrick Sek Tong Ong; Ya-Juan Wang; Yun Lei Tan; John R Yates; Ting-Wei Mu; Jeffery W Kelly
Journal:  Chem Biol       Date:  2013-02-21

3.  A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis.

Authors:  Yoshihiro Ishikawa; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

4.  Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.

Authors:  Steven Mumm; Gary S Gottesman; Deborah Wenkert; Philippe M Campeau; Angela Nenninger; Margaret Huskey; Vinieth N Bijanki; Deborah J Veis; Aileen M Barnes; Joan C Marini; Marina Stolina; Fan Zhang; William H McAlister; Michael P Whyte
Journal:  Bone       Date:  2019-08-28       Impact factor: 4.398

5.  Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families.

Authors:  Osama Essawi; Sofie Symoens; Maha Fannana; Mohammad Darwish; Mohammad Farraj; Andy Willaert; Tamer Essawi; Bert Callewaert; Anne De Paepe; Fransiska Malfait; Paul J Coucke
Journal:  Mol Genet Genomic Med       Date:  2017-11-18       Impact factor: 2.183

6.  Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.

Authors:  G A Otaify; M S Aglan; M M Ibrahim; M Elnashar; R A S El Banna; S A Temtamy
Journal:  Osteoporos Int       Date:  2015-07-03       Impact factor: 4.507

7.  Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix.

Authors:  Aileen M Barnes; Wayne A Cabral; MaryAnn Weis; Elena Makareeva; Edward L Mertz; Sergey Leikin; David Eyre; Carlos Trujillo; Joan C Marini
Journal:  Hum Mutat       Date:  2012-07-16       Impact factor: 4.878

8.  WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.

Authors:  Shawna M Pyott; Thao T Tran; Dru F Leistritz; Melanie G Pepin; Nancy J Mendelsohn; Renee T Temme; Bridget A Fernandez; Solaf M Elsayed; Ezzat Elsobky; Ishwar Verma; Sreelata Nair; Emily H Turner; Joshua D Smith; Gail P Jarvik; Peter H Byers
Journal:  Am J Hum Genet       Date:  2013-03-14       Impact factor: 11.025

Review 9.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

10.  Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations.

Authors:  Aileen M Barnes; Geraldine Duncan; Maryann Weis; William Paton; Wayne A Cabral; Edward L Mertz; Elena Makareeva; Michael J Gambello; Felicitas L Lacbawan; Sergey Leikin; Andrzej Fertala; David R Eyre; Sherri J Bale; Joan C Marini
Journal:  Hum Mutat       Date:  2013-07-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.